MARLBOROUGH, Mass.--(BUSINESS WIRE)--Acton Pharmaceuticals, Inc. (Acton), a specialty pharmaceutical company focused on developing respiratory therapies, announced today the formation of the company’s scientific advisory board. The eight advisory board members, who are each acknowledged as opinion leaders in the field of respiratory care, will play a key role in advising Acton on its current and future research and development programs and corporate strategy relating to improving asthma and respiratory care in the U.S.
